🔎 Trials Near Me

Home › Overweight › Nevada › Las Vegas

Pag-aaral pangklinika para sa Overweight sa Las Vegas, NV

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Las Vegas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2
  • Vector Clinical Trials /ID# 282265, Las Vegas
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3
  • Palm Research Center Inc., Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3
  • M3 Wake Research - Las Vegas Cimarron, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Nagre-recruitPhase 3
  • Palm Research Center Tenaya, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3
  • Excel Clinical Research, Las Vegas
  • Vector Clinical Trials, Las Vegas
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3
  • AMR Clinical, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Las Vegas Medical Research, Las Vegas
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3
  • AURORA-1 Clinical Site, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3
  • AURORA-2 Clinical Site, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • ACCOMPLISH-2 Research Site, Las Vegas
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Nagre-recruitPhase 3
  • Jubilee Clinical Research, Inc., Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2
  • Las Vegas Medical Research, Las Vegas
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Nagre-recruitPhase 2
  • Vector Clinical Trials, Las Vegas
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3
  • Palm Research Center Inc, Las Vegas
  • Vector Clinical Trials, Las Vegas
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3
  • Palm Research Center Inc, Las Vegas
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3
  • Excel Clinical Research, Las Vegas
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • University of Nevada, Las Vegas, Las Vegas
Edad 21 hanggang 74 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, Las Vegas
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3
  • ACCOMPLISH-1 Research Site, Las Vegas
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Nagre-recruitPhase 1
  • Corxel Investigational site, Las Vegas
Edad 18 hanggang 55 · Kababaihan · Na-update Hun 17, 2026 · NCT07652047

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Las Vegas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.